GlassScriptPhysician profile
Brian D Whitson
NPI 1053355073
$21,457.81
in general payments reported to CMS, 2019-2025
41 companies · $4,788 in 2025
The $4,788 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,460 · 2020: $1,950 · 2021: $2,237 · 2022: $4,375 · 2023: $2,847 · 2024: $3,802 · 2025: $4,788.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $63.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,372.19 |
| Education | $63.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $4,328.12 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $2,561.33 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,919.30 | 2019-2025 | Ofev, Spiriva Respimat, Jascayd |
| Genentech USA, INC. | $1,726.27 | 2019-2024 | Xolair |
| Insmed, INC. | $1,593.07 | 2020-2025 | Arikayce, Brinsupri |
| Genzyme Corporation | $1,198.36 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,179.84 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $949.33 | 2019-2024 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $844.26 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Mylan Specialty L.P. | $676.29 | 2019-2024 | Yupelri |
| Amgen INC. | $565.12 | 2021-2025 | Tezspire |
| Novartis Pharmaceuticals Corporation | $398.71 | 2020-2025 | |
| Sunovion Pharmaceuticals INC. | $355.15 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $328.98 | 2019-2025 | Winrevair, Capvaxive |
| United Therapeutics Corporation | $296.45 | 2019-2025 | Tyvaso, Tyvaso |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $286.73 | 2025 | Ohtuvayre |
| Pfizer INC. | $279.66 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $230.65 | 2022-2025 | Glassia |
| Baxter Healthcare | $218.49 | 2022-2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Viatris Specialty LLC | $204.43 | 2025 | Yupelri |
| Pulmonx Corporation | $192.66 | 2024-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Jazz Pharmaceuticals INC. | $181.57 | 2024-2025 | |
| Electromed, INC. | $179.19 | 2019-2025 | Smartvest |
| Fisher & Paykel Healthcare INC | $114.44 | 2019 | |
| Philips North America LLC | $67.95 | 2022-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Optinose US, INC. | $67.63 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $63.99 | 2024 | |
| Ani Pharmaceuticals, INC. | $57.05 | 2022 | |
| Vifor Pharma, INC. | $52.32 | 2024-2025 | Zemaira |
| Inogen, INC. | $51.14 | 2025 | |
| Fujifilm Healthcare Americas Corporation | $35.22 | 2024 | Fujifilm |
| Abbvie INC. | $34.88 | 2024 | |
| Harmony Biosciences LLC | $34.15 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $31.16 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $28.51 | 2025 | Ultomiris |
| Mallinckrodt Enterprises LLC | $24.49 | 2019 | |
| Inspire Medical Systems, INC. | $24.45 | 2024 | Inspire |
| Mallinckrodt Hospital Products INC. | $22.39 | 2022 | |
| Circassia INC. | $22.37 | 2019-2020 | |
| Lilly USA, LLC | $20.43 | 2025 | Zepbound |
| Intuitive Surgical, INC. | $11.28 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Whitson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.